We are live on
!
Find out more
TGI
TRV GP II Portfolio holdings
AUM
$1.34M
1-Year Est. Return
67.55%
This Fund
S&P 500
This Quarter
Est. Return
+60.65%
1 Year Est. Return
-67.55%
3 Year Est. Return
-20.84%
5 Year Est. Return
-49.87%
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$52.7M
(+52%)
Cap. Flow
-$3.58M
Cap. Flow
% of AUM
-2.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$3.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
IVAV
VM
CL
GAM
MC
NC
HCIG
NP
TRV GP II's Q1 2019 Portfolio in Review
As of Q1 2019, TRV GP II held 4 positions worth $153M, up 52% from $101M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP II's Q1 2019 filing shows 1 closed position. The largest sale was Sage Therapeutics, an estimated $3.58M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP II fully exited Sage Therapeutics in Q1 2019, selling an estimated $3.58M.
- TRV GP II's ten largest holdings make up 100% of its $153M portfolio in Q1 2019.
- TRV GP II opened 0 new positions and closed 1 in Q1 2019.
- TRV GP II's portfolio value rose 52% quarter-over-quarter to $153M.
Based on TRV GP II's 13F filing for Q1 2019, filed 3 May 2019.